A Study to Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Adult Participants With Chronic Kidney Disease and High Proteinuria

Clinical trial NCT06942910 · RECRUITING

Trial details

NCT number: NCT06942910
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Kidney Disease With High Proteinuria

Start date: 2025-05-07
Primary completion: 2026-07-31
Enrollment: 224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.